ALX Oncology Holdings Inc.
NASDAQ:ALXO
0.5547 (USD) • At close June 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 2.48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.527 | 0.655 | 1.213 | 1.256 | 1.295 | 1.032 |
| Cost of Revenue
| 0 | 0 | 0 | 0.22 | 0.214 | 0.207 | 0.209 | 0.513 | 0.518 | 0.413 | 0 | 0.28 | 0.376 | 0.259 | 0.262 | 0.152 | 0.005 | 0 | 0 | 0.479 | 0.596 | 1.103 | 1.142 | 1.177 | 0.938 |
| Gross Profit
| 0 | 0 | 0 | -0.22 | -0.214 | 2.273 | -0.209 | -0.513 | -0.518 | -0.413 | 0 | -0.28 | -0.376 | -0.259 | -0.262 | -0.152 | -0.005 | 0 | 0 | 0.048 | 0.059 | 0.11 | 0.114 | 0.118 | 0.094 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0.917 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.091 | 0 | 0.091 | 0.09 | 0.091 | 0.091 | 0.091 | 0.091 |
| Reseach & Development Expenses
| 23.888 | 23.532 | 26.471 | 34.653 | 31.717 | 41.784 | 45.766 | 29.482 | 24.763 | 25.197 | 29.382 | 26.748 | 17.073 | 20.894 | 18.214 | 11.213 | 9.849 | 12.142 | 5.328 | 7.663 | 3.828 | 6.735 | 2.21 | 3.628 | 3.733 |
| General & Administrative Expenses
| 7.932 | 7.081 | 6.096 | 6.872 | 6.045 | 6.239 | 7.509 | 7.295 | 7.44 | 7.022 | 7.299 | 7.041 | 7.674 | 7.578 | 6.362 | 5.086 | 4.359 | 5.683 | 4.481 | 3.172 | 1.473 | 1.108 | 0.938 | 0.679 | 0.588 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -0.22 | -0.214 | -0.207 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 7.932 | 7.081 | 6.096 | 6.652 | 5.831 | 6.032 | 7.509 | 7.295 | 7.44 | 7.022 | 7.299 | 7.041 | 7.674 | 7.578 | 6.362 | 5.086 | 4.359 | 5.683 | 4.481 | 3.172 | 1.473 | 1.108 | 0.938 | 0.679 | 0.588 |
| Other Expenses
| 0 | 0 | 0 | -0.008 | -0.014 | -0.029 | -0.001 | 0.324 | 0.095 | -0.233 | -0.009 | -0.007 | -0.011 | 0.016 | 0.014 | 0.028 | 0.026 | 0.005 | -0.111 | -0.305 | 0.007 | -0.001 | -0.002 | 0 | -0.002 |
| Operating Expenses
| 31.82 | 30.613 | 32.567 | 41.305 | 37.548 | 47.816 | 53.275 | 36.777 | 32.203 | 32.219 | 36.681 | 33.789 | 24.747 | 28.472 | 24.576 | 16.299 | 14.208 | 17.825 | 9.809 | 10.835 | 5.301 | 7.843 | 3.148 | 4.307 | 4.321 |
| Operating Income
| -31.82 | -30.613 | -32.567 | -41.525 | -37.762 | -48.023 | -53.275 | -36.777 | -32.203 | -32.219 | -36.681 | -33.789 | -24.747 | -28.472 | -24.576 | -16.299 | -14.208 | -17.825 | -9.809 | -10.787 | -5.242 | -7.733 | -3.034 | -4.189 | -4.227 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | -19.364 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15,080,372.25 | 0 | -20.469 | -8.003 | -6.375 | -2.416 | -3.235 | -4.096 |
| Total Other Income Expenses Net
| 1.066 | 1.45 | 1.86 | 2.126 | 2.181 | 2.551 | 2.285 | 2.618 | 2.019 | 1.574 | 1.361 | 0.869 | 0.214 | 0.013 | 0.01 | 0.025 | 0.023 | -0.767 | -0.337 | -0.524 | -0.208 | -0.022 | -0.002 | 0 | -0.002 |
| Income Before Tax
| -30.754 | -29.163 | -30.707 | -39.399 | -35.581 | -45.472 | -50.99 | -34.159 | -30.184 | -30.645 | -35.32 | -32.92 | -24.533 | -28.459 | -24.566 | -16.274 | -14.185 | -18.592 | -10.146 | -11.311 | -5.45 | -7.755 | -3.036 | -4.189 | -4.229 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | -18.335 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15,729,272.42 | 0 | -21.463 | -8.321 | -6.393 | -2.417 | -3.235 | -4.098 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0.171 | 1.145 | -0.209 | 0.696 | -1.632 | 0.064 | -1.37 | -0.869 | -0.214 | -0.021 | 0.018 | 0.031 | 0.029 | 0.182 | 0.035 | 0.02 | 0.004 | 0.009 | 0.008 | 0.008 | 0.009 |
| Net Income
| -30.754 | -29.163 | -30.707 | -39.399 | -35.581 | -45.472 | -50.99 | -34.159 | -28.552 | -30.709 | -35.32 | -32.051 | -24.319 | -28.438 | -24.566 | -16.274 | -14.185 | -18.774 | -10.181 | -11.331 | -5.454 | -7.764 | -3.044 | -4.197 | -4.238 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | -18.335 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15,883,248.731 | 0 | -21.501 | -8.327 | -6.401 | -2.424 | -3.241 | -4.107 |
| EPS
| -0.58 | -0.55 | -0.58 | -0.76 | -0.71 | -0.93 | -1.24 | -0.84 | -0.7 | -0.75 | -0.87 | -0.79 | -0.6 | -0.7 | -0.61 | -0.4 | -0.35 | -0.5 | -0.34 | -0.33 | -0.16 | -0.35 | -0.14 | -0.19 | -0.19 |
| EPS Diluted
| -0.58 | -0.55 | -0.58 | -0.76 | -0.71 | -0.93 | -1.24 | -0.84 | -0.7 | -0.75 | -0.87 | -0.79 | -0.6 | -0.7 | -0.61 | -0.4 | -0.35 | -0.5 | -0.34 | -0.33 | -0.16 | -0.35 | -0.14 | -0.19 | -0.19 |
| EBITDA
| -31.82 | -28.522 | -30.037 | -38.75 | -34.94 | -44.85 | -50.39 | -33.274 | -29.279 | -32.114 | -34.923 | -32.64 | -24.157 | -28.422 | -24.556 | -16.265 | -14.203 | -18.436 | -9.915 | -11.013 | -5.122 | -7.622 | -2.925 | -4.08 | -4.132 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | -18.085 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15,597,292.724 | 0 | -20.898 | -7.82 | -6.284 | -2.329 | -3.151 | -4.004 |